A bill to amend the Pharmaceutical and Medical Devices (PMD) Law is expected to be submitted to the ordinary session of the Diet this year, which was convened on January 17 for a 150-day run. The proposed amendment is for…
HOME > TOP STORIES
TOP STORIES
-
ORGANIZATION JGA Begins Posting Information on Out-of-Stock Products, Delayed Shipments on Website
July 3, 2012
-
BUSINESS Otsuka, Kyowa Kirin Announce Strategic Alliance in Fields of Diabetes, Oncology
July 2, 2012
-
REGULATORY JPO Rules Actonel Patent Invalid; Ajinomoto Considering Appeal
June 29, 2012
-
ACADEMIA Univ. of Tokyo Hospital’s New “Phase I Unit” to Initiate Trials for Takeda’s TAK-070 for AD
June 28, 2012
-
BUSINESS Eisai to Make Full-Scale Entry into Russian Market; Antiepileptic Agent Obtains Approval
June 28, 2012
-
REGULATORY MHLW Talks to Drug Makers with Facilities Eligible for Exemption from Planned Power Outages
June 27, 2012
-
REGULATORY MHLW Orders Updates from Chugai Following Criticism for Reporting Deficiencies by Roche in US
June 26, 2012
-
ORGANIZATION JPWA, NPhA Confirm Need for Thorough Efforts “at Ground Level” for Distribution Improvements
June 25, 2012
-
REGULATORY MHLW to Strengthen Focus on Dementia with Budget Request for FY2013
June 22, 2012
-
REGULATORY 60% Rule Applied for 3 APIs in June’s Generic Listing
June 22, 2012
-
REGULATORY PMDA’s Science Committee Holds 1st Meeting; Will Work to Improve Review Quality through Exchanges with Researchers
June 20, 2012
-
ORGANIZATION Products from 2nd Round of Development Requests Now Eligible for PDSC Subsidies
June 19, 2012
-
REGULATORY DPJ Approves Draft Bill to Establish 3rd-Party Organization; Will Seek Discussions with Opposition
June 18, 2012
-
BUSINESS Top 100 Products in FY2011: Pronounced Growth for ARB Combinations with Declining Sales of Monodrugs
June 15, 2012
-
BUSINESS Sanofi, Hisamitsu to Form JV for Allergy-Related OTCs, Seen Eyeing Allegra OTC Launch
June 14, 2012
-
REGULATORY Ryukaikon’s Working Team Prepares to Start Operations by End of June; Beginning with Exchange of Opinions between JPWA, NPhA
June 13, 2012
-
BUSINESS Sawai Considers Leveraging “MSs with MR Qualifications” with Medipal Group
June 12, 2012
-
BUSINESS University of Tokyo Hospital to Take Over Development of Takeda’s AD Treatment Candidate
June 11, 2012
-
REGULATORY Expert Subcommittee Begins Discussions on Pricing of Long-Listed Drugs with Focus on Differences from Generic Prices
June 8, 2012
-
BUSINESS Mr Mark Swindell Appointed Head of Specialty Care: Pfizer Japan
June 7, 2012
ページ
A total of 15 new drugs (APIs) joined the NHI price list in 2021 with peak sales forecasts topping at 10 billion yen, many of them in the area of orphan diseases and with few mega launches, according to a…
Japan’s all-important reimbursement policy panel on December 22 approved an outline of the next drug pricing reform scheduled for April 2022, which embraces plans to reward innovative new indications and introduce a grace period for so-called “spillover” re-pricing.The reform outline…
Remember what it was like back in March, when we all started working from home? There was a distinct change in the air - a sense of freedom and excitement about the novelty of being able to work from home.…
Biogen’s controversial Alzheimer’s drug aducanumab was filed for Japanese regulatory approval in December. If approved, it will be the first…
Japan will go ahead with the introduction of a cost-effectiveness assessment (CEA) scheme for drugs and medical devices in April…